NUMD — Nu-Med Plus Cashflow Statement
0.000.00%
- $4.18m
- $4.28m
Annual cashflow statement for Nu-Med Plus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2.01 | -0.83 | -0.13 | -0.126 | -0.068 |
Depreciation | |||||
Non-Cash Items | 1.56 | 0.191 | -0.015 | 0.042 | 0 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.012 | 0.411 | 0.096 | 0.017 | 0.064 |
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | -0.415 | -0.207 | -0.038 | -0.066 | -0.004 |
Other Investing Cash Flow Items | 0 | — | — | — | 0 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0 | — | — | — | 0 |
Financing Cash Flow Items | — | — | — | — | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.596 | 0.03 | 0.1 | 0 | 0 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.181 | -0.177 | 0.062 | -0.066 | -0.004 |